According to the latest data from the Hong Kong Stock Exchange, Norges Bank reduced its stake in Pharmaron (03759) by 3.6595 million shares on January 5, with a transaction price of HK$20.6572 per share, totaling approximately HK$75.595 million.
Following this disposal, its latest shareholding amounts to approximately 14.5457 million shares, representing a holding percentage of 4.94%.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments